BIOMAT Database Logo BIOMAT Database Logo

Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells. 2014

Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

OBJECTIVE To compare cytotoxic effects and antiviral efficacy of 9 nucleoside reverse transcriptase inhibitors (NRTIs) against FIV in feline peripheral blood mononuclear cells. METHODS Peripheral blood mononuclear cells obtained from 3 specific pathogen-free cats. METHODS 3 of the 9 NRTIs had not been previously assessed in feline cell lines. Cytotoxic effects were determined by colorimetric quantification of a formazan product resulting from bioreduction of a tetrazolium reagent by viable peripheral blood mononuclear cells; uninfected cells from 1 cat were used in these assays. Cells from all 3 cats were infected with a pathogenic clone of FIV, and in vitro antiviral efficacy of each NRTI was assessed with an FIV p24 antigen capture ELISA. RESULTS Cytotoxic effects in feline peripheral blood mononuclear cells were observed only at concentrations > 10 μM for all 9 NRTIs. Comparison of the cytotoxic effect at the highest concentration investigated (500 μM) revealed that didanosine and amdoxovir were significantly less toxic than abacavir. All drugs induced a dose-dependent reduction of FIV replication. At the highest concentration investigated (10 μM), there was no significant difference in antiviral efficacy among the test compounds. CONCLUSIONS The evaluated NRTIs had low cytotoxicity against feline peripheral blood mononuclear cells and appeared to be safe options for further in vivo evaluation for the treatment of FIV-infected cats. There was no evidence suggesting that the newly evaluated compounds would be superior to the existing NRTIs for reducing FIV burden of infected cats.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D016089 Immunodeficiency Virus, Feline A species of LENTIVIRUS, subgenus feline lentiviruses (LENTIVIRUSES, FELINE) isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma (FIP-P), Oma (FIP-O) and Puma lentivirus (PLV). There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells. FIV,FTLV,Feline Immunodeficiency Virus,Feline T-Lymphotropic Lentivirus,Lentivirus, Puma,Puma lentivirus,Feline T-Lymphotropic Virus,Feline Immunodeficiency Viruses,Feline T Lymphotropic Lentivirus,Feline T Lymphotropic Virus,Lentivirus, Feline T-Lymphotropic,T-Lymphotropic Lentivirus, Feline,T-Lymphotropic Virus, Feline
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
January 2004, Molecular pharmacology,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
January 2004, Current topics in medicinal chemistry,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
[Non-nucleoside reverse transcriptase inhibitors of the human immunodeficiency virus].
November 1998, Medicina clinica,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Biochemical and structural comparisons of non-nucleoside reverse transcriptase inhibitors against feline and human immunodeficiency viruses.
September 2023, Journal of veterinary science,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus.
December 2015, Veterinary sciences,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.
July 2002, Antimicrobial agents and chemotherapy,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.
February 2002, Molecular pharmacology,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.
September 2005, Journal of virology,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Nucleoside reverse transcriptase inhibitors and resistance of human immunodeficiency virus type 1.
March 1995, The Journal of infectious diseases,
Anita M Schwartz, and Mary Ann McCrackin, and Raymond F Schinazi, and Peter B Hill, and Thomas W Vahlenkamp, and Mary B Tompkins, and Katrin Hartmann
Characterization of reverse transcriptase from feline immunodeficiency virus.
March 1990, The Journal of biological chemistry,
Copied contents to your clipboard!